Summarized by Masters of Longevity from Science Daily - Health & Medicine.
Bone research news outlines a lab study on a molecular switch, inviting readers to consider experimental methods and clinical implications.
Key Takeaways
- AP503 activated the adhesion GPCR GPR133 to increase bone formation in mice.
- Treatment both boosted bone strength and slowed bone loss in the mouse model.
- Prior work links GPR133 activation with improved muscle strength, suggesting dual benefits.
